A call from the European Academy of Neurology on COVID-19

Foundation Models in Sleep Research: Opportunities and Limitations.

Sleep·2026

Evaluating discrimination of prediction models for recurrent clinical events.

Diagnostic and prognostic research·2026

Climate Change, Neurological Disorders and Brain Health: To-Know Concepts and Future Actions by the EAN Environmental Influences in Neurology Task Force.

European journal of neurology·2026

Insufficient sleep syndrome: A single center (Bern) experience over 20 years in diagnosis and management.

Sleep medicine·2026

The International Alliance on Brain Health (IABH): Bridging global efforts toward integrated brain and mental health plans and the promotion of local implementations.

Journal of the neurological sciences·2026

The economic burden of dementia in Europe: COIN-Eu dementia.

Journal of Alzheimer's disease : JAD·2026

Plasma phosphorylated tau 217 concentrations, APOE genotype, and timing of cognitive impairment in individuals across diverse racial and ethnic groups: a pooled analysis of prospective cohort studies.

The Lancet. Neurology·2026

Clinical pathways for cognitively unimpaired individuals with Alzheimer's disease neuropathological change.

The Lancet. Neurology·2026

Neuroimaging in the era of biologically defined Alzheimer's disease and disease-modifying therapy.

The Lancet. Neurology·2026

Fluid biomarkers in the evolving care landscape of Alzheimer's disease and related disorders.

The Lancet. Neurology·2026

Safety, tolerability, and efficacy of RIPK1 inhibitor, SAR443820, in amyotrophic lateral sclerosis (HIMALAYA): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.

The Lancet. Neurology·2026

Prevalence of unruptured intracranial aneurysms according to comorbidities, risk factors, country, and time period: a systematic review and meta-analysis.

The Lancet. Neurology·2026

Efficacy and Safety of DL-3-n-Butylphthalide in Spinocerebellar Ataxia Type 3.

Movement disorders : official journal of the Movement Disorder Society·2026

Altered neurovascular coupling in mild cognitive impairment and Alzheimer's disease: Associations with polysomnography-derived sleep parameters and cognition.

Journal of Alzheimer's disease : JAD·2026

Neuromodulation in African Health Systems: Barriers, Opportunities, and Future Directions.

Neuromodulation : journal of the International Neuromodulation Society·2026

Neural Stem Cell-Derived Extracellular Vesicles Improve CNS Delivery and Therapeutic Efficacy of Antisense Oligonucleotide in Amyotrophic Lateral Sclerosis.

Journal of extracellular vesicles·2026

Resilience mechanisms in Parkinson's disease: a domain-specific conceptual framework.

Brain : a journal of neurology·2026

Structural abnormalities in gray matter, white matter, and cerebrospinal fluid in parkinson's disease: a voxel-based morphometry study.

Neurological research·2026

Related Experiment Videos

A call from the European Academy of Neurology on COVID-19

Related Concept Videos

Foundation Models in Sleep Research: Opportunities and Limitations.

Evaluating discrimination of prediction models for recurrent clinical events.

Climate Change, Neurological Disorders and Brain Health: To-Know Concepts and Future Actions by the EAN Environmental Influences in Neurology Task Force.

Insufficient sleep syndrome: A single center (Bern) experience over 20 years in diagnosis and management.

The International Alliance on Brain Health (IABH): Bridging global efforts toward integrated brain and mental health plans and the promotion of local implementations.

The economic burden of dementia in Europe: COIN-Eu dementia.

Plasma phosphorylated tau 217 concentrations, APOE genotype, and timing of cognitive impairment in individuals across diverse racial and ethnic groups: a pooled analysis of prospective cohort studies.

Clinical pathways for cognitively unimpaired individuals with Alzheimer's disease neuropathological change.

Neuroimaging in the era of biologically defined Alzheimer's disease and disease-modifying therapy.

Fluid biomarkers in the evolving care landscape of Alzheimer's disease and related disorders.

Safety, tolerability, and efficacy of RIPK1 inhibitor, SAR443820, in amyotrophic lateral sclerosis (HIMALAYA): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.

Prevalence of unruptured intracranial aneurysms according to comorbidities, risk factors, country, and time period: a systematic review and meta-analysis.

Efficacy and Safety of DL-3-n-Butylphthalide in Spinocerebellar Ataxia Type 3.

Altered neurovascular coupling in mild cognitive impairment and Alzheimer's disease: Associations with polysomnography-derived sleep parameters and cognition.

Neuromodulation in African Health Systems: Barriers, Opportunities, and Future Directions.

Neural Stem Cell-Derived Extracellular Vesicles Improve CNS Delivery and Therapeutic Efficacy of Antisense Oligonucleotide in Amyotrophic Lateral Sclerosis.

Resilience mechanisms in Parkinson's disease: a domain-specific conceptual framework.

Structural abnormalities in gray matter, white matter, and cerebrospinal fluid in parkinson's disease: a voxel-based morphometry study.

Related Experiment Videos

A call from the European Academy of Neurology on COVID-19

Related Concept Videos

Related Articles